Skip to main content
. 2023 Apr 24;6:0124. doi: 10.34133/research.0124

Table.

Characterization of our novel anti-RBD antibodies on RBD-induced platelet activation.

Clone name IgG subtype Inhibit RBD–ACE2 binding Inhibit RBD-PLT binding Inhibit P-selectin Inhibit PAC-1 Inhibit fibrinogen
4F2 IgG 1 Strong Yes Yes (*) Yes Yes (*)
4H10 IgG 2a Weak Yes Yes Yes (*) Yes (**)
2B5 IgG 2a Weak Yes Yes Yes (*) Yes (*)
4E10 IgG 2b Weak Yes Yes Yes Yes
4H12 IgG 1 Strong Yes Yes Yes (**) Yes

*P < 0.05, **P < 0.01, RBD + anti-RBD mAb vs. RBD + mIgG control.